Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AZURITY

  • FDA Approval
  • April 22, 2024, 08:53 UTC
  • 47
  • 0 comments

FDA approve BACLOFEN

Comment Full text

HIKMA

  • FDA Approval
  • April 22, 2024, 08:53 UTC
  • 50
  • 0 comments

FDA approve METHAMPHETAMINE HYDROCHLORIDE

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • April 19, 2024, 19:45 UTC
  • 46
  • 0 comments

FDA approve VEDOLIZUMAB

Comment Full text

HOFFMANN-LA ROCHE

  • FDA Approval
  • April 19, 2024, 19:05 UTC
  • 48
  • 0 comments

FDA approve ALECTINIB HYDROCHLORIDE

Comment Full text

HETERO LABS

  • FDA Approval
  • April 19, 2024, 16:26 UTC
  • 48
  • 0 comments

FDA approve ERTUGLIFLOZIN

Comment Full text

VIIV HLTHCARE

  • FDA Approval
  • April 19, 2024, 08:56 UTC
  • 51
  • 0 comments

FDA approve ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Comment Full text

INFORLIFE

  • FDA Approval
  • April 19, 2024, 08:56 UTC
  • 45
  • 0 comments

FDA approve NICARDIPINE HYDROCHLORIDE

Comment Full text

PANACEA

  • FDA Approval
  • April 19, 2024, 08:56 UTC
  • 46
  • 0 comments

FDA approve PRASUGREL HYDROCHLORIDE

Comment Full text

VIIV HLTHCARE

  • FDA Approval
  • April 19, 2024, 08:56 UTC
  • 43
  • 0 comments

FDA approve ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Comment Full text

LEADING

  • FDA Approval
  • April 19, 2024, 04:58 UTC
  • 51
  • 0 comments

FDA approve METOLAZONE

Comment Full text
  • Previous
  • 472
  • 473
  • 474
  • 475
  • 476
  • Next

Search

News categories

  • Technical Exchange News(12448)
  • Event(6229)
  • SEC News(278889)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(160198)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin